Correlation Between Ihuman and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ihuman and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ihuman and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ihuman Inc and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Ihuman and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ihuman with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ihuman and Tarsus Pharmaceuticals.
Diversification Opportunities for Ihuman and Tarsus Pharmaceuticals
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ihuman and Tarsus is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Ihuman Inc and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Ihuman is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ihuman Inc are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Ihuman i.e., Ihuman and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ihuman and Tarsus Pharmaceuticals
Allowing for the 90-day total investment horizon Ihuman Inc is expected to under-perform the Tarsus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Ihuman Inc is 1.21 times less risky than Tarsus Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Tarsus Pharmaceuticals is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,827 in Tarsus Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 3,418 from holding Tarsus Pharmaceuticals or generate 187.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ihuman Inc vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Ihuman Inc |
| Tarsus Pharmaceuticals |
Ihuman and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ihuman and Tarsus Pharmaceuticals
The main advantage of trading using opposite Ihuman and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ihuman position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Ihuman vs. Wah Fu Education | Ihuman vs. Golden Sun Education | Ihuman vs. Elite Education Group | Ihuman vs. QuantaSing Group Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |